Oregon Public Employees Retirement Fund
MCRB icon

Oregon Public Employees Retirement Fund’s Seres Therapeutics MCRB Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,464
Closed -$636K – 1561
2022
Q1 		$636K Hold
4,464
– – 0.01% 1306
2021
Q4 		$744K Hold
4,464
– – 0.01% 1150
2021
Q3 		$621K Hold
4,464
– – 0.01% 1227
2021
Q2 		$2.13M Hold
4,464
– – 0.02% 599
2021
Q1 		$1.84M Hold
4,464
– – 0.02% 630
2020
Q4 		$2.19M Buy
+4,464
New +$2.61M 0.03% 497

Other funds holding MCRB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Maven Securities
Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return

Oregon Public Employees Retirement Fund's MCRB Position: Q2 2022 in Review

Oregon Public Employees Retirement Fund sold out of Seres Therapeutics (MCRB) in Q2 2022, closing a stake of 4,464 shares — an estimated $636K sold.

Oregon Public Employees Retirement Fund first reported a position in MCRB in Q4 2020 and held it in 6 quarters. The position peaked at $2.19M in Q4 2020. 123 funds tracked by Wall St. Rank hold MCRB as of Q2 2022.

  • Oregon Public Employees Retirement Fund reported no remaining Seres Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Oregon Public Employees Retirement Fund sold 4,464 Seres Therapeutics shares in Q2 2022, an estimated $636K.
  • Oregon Public Employees Retirement Fund first reported a position in Seres Therapeutics in Q4 2020 and held it in 6 quarters.
  • Oregon Public Employees Retirement Fund's Seres Therapeutics position peaked at $2.19M in Q4 2020.
  • 123 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2022.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2022, filed 25 Jul 2022.